The global Vitamin K2 market was 86.3 million US$ in 2018 and is expected to 406 million US$ by the end of 2025, growing at a CAGR of 24.6% between 2019 and 2025.

This report studies the Vitamin K2 market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Vitamin K2 in these regions, from 2014 to 2025, covering
North America (the United States, Canada and Mexico)
Europe (Germany, UK, France, Italy and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia)
South America (Brazil etc.)
The Middle East and Africa

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The Vitamin K2 key manufacturers in this market include:
Kappa Bioscience
NattoPharma
Gnosis
DSM
Viridis BioPharma
Frutarom
DuPont Nutrition & Health
GeneFerm Biotechnology
Shanghai Reson Biotech
Guangdong Goodscend
Seebio Biotech
Kyowa Hakko

By the product type, the market is primarily split into:
MK-7
MK-4
Other (MK-9 etc.)

By the end users/application, this report covers the following segments:
Powder
Oil